Pfizer, Ranbaxy Look To Dump State Claims In Lipitor MDL
By Chuck Stanley ( April 17, 2018, 7:47 PM EDT) -- Pfizer Inc. and generic-drug maker Ranbaxy Inc. asked a New Jersey federal court Monday to quash state law claims in multidistrict litigation from a group of Lipitor buyers that say the companies participated in an illegal pay-for-delay scheme to keep a generic version of the cholesterol drug out of the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.